Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-17

Clinical Trial Update: Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of oxfendazole in healthy adults completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxfendazole (oxfendazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Helminthic Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-12-17